Introduction to Tenofovir Alafenamide in PLHIV with renal impairment Facilitator: Dr. Lazarus Momanyi

Description

Clinical case scenarios ART optimization and monitoring in Kenya TAF LD: Basic pharmacology, clinical evidence for use Eligibility criteria for TAF LD in Kenya Clinical risk stratification and diagnosis of osteoporosis Side effects and drug drug interactions Active toxicity monitoring and pharmacovigilance Commodity update Q & A

Objectives

Presenters

1. Dr. Lazarus Makori
   Dr. Lazarus Momanyi Technical Advisor for HIV Differentiated Service Delivery (DSD) Kenya Ministry of Health, National AIDS & STI Control Program (NASCOP) ___________________________________________
   NASCOP